Correlation Between Pliant Therapeutics and Scpharmaceuticals

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Pliant Therapeutics and Scpharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Pliant Therapeutics and Scpharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Pliant Therapeutics and Scpharmaceuticals, you can compare the effects of market volatilities on Pliant Therapeutics and Scpharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Pliant Therapeutics with a short position of Scpharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Pliant Therapeutics and Scpharmaceuticals.

Diversification Opportunities for Pliant Therapeutics and Scpharmaceuticals

-0.21
  Correlation Coefficient

Very good diversification

The 3 months correlation between Pliant and Scpharmaceuticals is -0.21. Overlapping area represents the amount of risk that can be diversified away by holding Pliant Therapeutics and Scpharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Scpharmaceuticals and Pliant Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Pliant Therapeutics are associated (or correlated) with Scpharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Scpharmaceuticals has no effect on the direction of Pliant Therapeutics i.e., Pliant Therapeutics and Scpharmaceuticals go up and down completely randomly.

Pair Corralation between Pliant Therapeutics and Scpharmaceuticals

Given the investment horizon of 90 days Pliant Therapeutics is expected to generate 1.14 times more return on investment than Scpharmaceuticals. However, Pliant Therapeutics is 1.14 times more volatile than Scpharmaceuticals. It trades about 0.05 of its potential returns per unit of risk. Scpharmaceuticals is currently generating about -0.14 per unit of risk. If you would invest  1,335  in Pliant Therapeutics on September 5, 2024 and sell it today you would earn a total of  128.00  from holding Pliant Therapeutics or generate 9.59% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Pliant Therapeutics  vs.  Scpharmaceuticals

 Performance 
       Timeline  
Pliant Therapeutics 

Risk-Adjusted Performance

4 of 100

 
Weak
 
Strong
Insignificant
Compared to the overall equity markets, risk-adjusted returns on investments in Pliant Therapeutics are ranked lower than 4 (%) of all global equities and portfolios over the last 90 days. In spite of fairly weak basic indicators, Pliant Therapeutics showed solid returns over the last few months and may actually be approaching a breakup point.
Scpharmaceuticals 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Scpharmaceuticals has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The recent confusion may also be a sign of long-lasting up-swing for the firm traders.

Pliant Therapeutics and Scpharmaceuticals Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Pliant Therapeutics and Scpharmaceuticals

The main advantage of trading using opposite Pliant Therapeutics and Scpharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Pliant Therapeutics position performs unexpectedly, Scpharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Scpharmaceuticals will offset losses from the drop in Scpharmaceuticals' long position.
The idea behind Pliant Therapeutics and Scpharmaceuticals pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Complementary Tools

Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals